The UC Davis Vascular Center Clinical Research Program is dedicated to providing the most innovative and progressive care to our patients, while at the same time contributing to the science of medicine by conducting clinical trials. Participation in clinical trials is one way UC Davis stays on the forefront of medicine.

Clinical trials currently enrolling subjects:

The PIVOTAL study is a multi-center randomized clinical trial comparing early repair of abdominal aortic aneurysms (AAA) to careful surveillance without AAA repair. This study seeks men and women between 40 and 90 years of age who have been diagnosed with an abdominal aortic aneurysm that is between 4.0 and 5.0 centimeters in size.

The purpose of this carotid stent study is to collect more information on the safety and effectiveness of the FDA approved ACCULINK Carotid Stent and ACCUNET embolic protection devices in patients who have been diagnosed with a severe narrowing of their carotid arteries. This study will collect information on any unanticipated or rare events associated with these devices.

The purpose of this clinical research study is to investigate the safety and effectiveness of an injectable gene therapy to promote the growth of new blood vessels within the lower extremities of patients with symptoms of intermittent claudication. This study seeks men and women between the age of 40 and 80 who have a history of peripheral arterial disease with symptoms of intermittent claudication.

For more information on these UC Davis Vascular Center clinical trials,  please call Christy Pifer, the division's clinical research coordinator, at (916) 734-4156.